Cannabist Company Holdings's quarterly market cap
increased
from Mar. 2025 ($23.0 Mil) to Jun. 2025 ($27.2 Mil) and
increased
from Jun. 2025 ($27.2 Mil) to Sep. 2025 ($57.4 Mil).
Cannabist Company Holdings's annual market cap
declined
from Dec. 2022 ($300.9 Mil) to Dec. 2023 ($193.4 Mil) and
declined
from Dec. 2023 ($193.4 Mil) to Dec. 2024 ($31.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cannabist Company Holdings's Enterprise Value for Today is $424.1 Mil.
Cannabist Company Holdings (OTCPK:CBSTQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cannabist Company Holdings Market Cap Related Terms
Cannabist Company Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabist Company Holdings Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Cannabist Company Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabist Company Holdings (CBSTQ) has a Market Cap of $0.1 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabist Company Holdings and its competitors.
Is Cannabist Company Holdings' Market Cap too high?
Cannabist Company Holdings' current Market Cap is $0.1 Mil. The Drug Manufacturers industry median Market Cap is 206.50. Cannabist Company Holdings' value of $0.1 Mil is 100% below this industry median.
How does Cannabist Company Holdings' Market Cap compare to ZTS?
Cannabist Company Holdings' Market Cap of $0.1 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.50. Cannabist Company Holdings' value of $0.1 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabist Company Holdings's current Market Cap of $0.1 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabist Company Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabist Company Holdings's current Market Cap is $0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Cannabist Company Holdings (CBSTQ) has a current Market Cap of $0.1 Mil. The stock's GF Value™ is $0.17, compared to a current price of $0.00 — trading 99.9% below its estimated fair value. The current Market Cap is $0.1 Mil and 100% below the Drug Manufacturers industry median of 206.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cannabist Company Holdings (CBSTQ), the current Market Cap is $0.1 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBSTQ has been successfully added to your 